A multilayer grow-or-go model for GBM: effects of invasive cells and anti-angiogenesis on growth. (Q48590155)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25149139%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

title

A multilayer grow-or-go model for GBM: effects of invasive cells and anti-angiogenesis on growth (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25149139%20AND%20SRC:MED&resulttype=core&format=json

Hassan M Fathallah-Shaykh

13 March 2020

author

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25149139%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Olivier Saut

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25149139%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Jean-Baptiste Lagaert

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25149139%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Thierry Colin

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25149139%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

publication date

23 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25149139%20AND%20SRC:MED&resulttype=core&format=json

Bulletin of Mathematical Biology

13 March 2020

number of pages

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25149139%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25149139%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25149139%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

2306-2333

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25149139%20AND%20SRC:MED&resulttype=core&format=json

maintained by WikiProject

13 March 2020

WikiProject Mathematics

0 references

cites work

Microenvironment driven invasion: a multiscale multimodel investigation

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

A pharmacologically based multiscale mathematical model of angiogenesis and its use in investigating the efficacy of a new cancer treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Realistic simulation of the 3-D growth of brain tumors in MR images coupling diffusion with biomechanical deformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Design and construction of a realistic digital brain phantom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Computer simulation of glioma growth and morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Evolution of cell motility in an individual-based model of tumour growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

The impact of phenotypic switching on glioblastoma growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

A randomized trial of bevacizumab for newly diagnosed glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

'Go or grow': the key to the emergence of invasion in tumour progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Image guided personalization of reaction-diffusion type tumor growth models using modified anisotropic eikonal equations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Extrapolating glioma invasion margin in brain magnetic resonance images: suggesting new irradiation margins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Multiscale modelling and nonlinear simulation of vascular tumour growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Emerging patterns in tumor systems: simulating the dynamics of multicellular clusters with an agent-based spatial agglomeration model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Density-dependent quiescence in glioma invasion: instability in a simple reaction-diffusion model for the migration/proliferation dichotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Hypoxia-induced tumour cell migration in an in vivo chicken model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

A phase 2 trial of single‐agent bevacizumab given in an every‐3‐week schedule for patients with recurrent high‐grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Modeling the influence of the E-cadherin-beta-catenin pathway in cancer cell invasion: a multiscale approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

A mathematical model of glioblastoma tumor spheroid invasion in a three-dimensional in vitro experiment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Quantifying the role of angiogenesis in malignant progression of gliomas: in silico modeling integrates imaging and histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

c-Src and neural Wiskott-Aldrich syndrome protein (N-WASP) promote low oxygen-induced accelerated brain invasion by gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Identification of intrinsic in vitro cellular mechanisms for glioma invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Angiogenesis inhibition for glioblastoma at the edge: beyond AVAGlio and RTOG 0825.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11538-014-0007-Y